Hao Jiang

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Ejection Fraction

Acute Lymphoblastic Leukemia

Cell Proliferation

Top Venues

Cancer gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Shubing Zhang, Jinhua Yan, Lan He, Zhiping Jiang, Hao Jiang
STAT5a and SH2B3 novel mutations display malignancy roles in a triple-negative primary myelofibrosis patient. Cancer gene therapy 31 (3) (2023)
Shubing Zhang, Jinhua Yan, Lan He, Zhiping Jiang, Hao Jiang
STAT5a and SH2B3 novel mutations display malignancy roles in a triple-negative primary myelofibrosis patient. Cancer gene therapy 31 (3) (2023)
Shubing Zhang, Jinhua Yan, Lan He, Zhiping Jiang, Hao Jiang
STAT5a and SH2B3 novel mutations display malignancy roles in a triple-negative primary myelofibrosis patient. Cancer gene therapy 31 (3) (2023)
Shubing Zhang, Jinhua Yan, Lan He, Zhiping Jiang, Hao Jiang
STAT5a and SH2B3 novel mutations display malignancy roles in a triple-negative primary myelofibrosis patient. Cancer gene therapy (2023)